miR-1296 is downregulated in TNBC cells when compared to a non-tumorigenic breast cell line, and in the majority of human triple negative breast cancer samples when compared to normal breast samples In silico algorithms and sequence alignments identified the CCND1 oncogene as a potential target. Here, CCND1 is linked to triple-negative breast carcinoma.